Oncology
GILOTRIF
Generic: afatinib
Manufacturer: Boehringer Ingelheim · Program: Boehringer Ingelheim Cares Foundation Patient Assistance Program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Program available to uninsured and underinsured patients; separate copay program available for commercially insured patients
Residency
US resident
Income eligibility criteria not specified in search results
Program Information
Processing Time
2-4 weeks
Delivery Method
shipped to patient
Application Method
Multiple
Reauthorization
Required — annual
Indicated For
Non-small cell lung cancer (NSCLC) with EGFR mutations
Program information last verified: March 30, 2026
Ready to apply for GILOTRIF assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.